Both in Biotechnology
Sutro Biopharma vs Humacyte
Over the past year STRO returned −15.9% and HUMA returned −72.3%; their daily moves had a correlation of 0.18.
STRO −15.9% HUMA −72.3%Growth of $1, one year, split-adjusted
| Metric | STRO | HUMA |
|---|---|---|
| Price | $9.15 | $0.4607 |
| Market cap | $151.7M | $128.0M |
| Today | +3.16% | +3.22% |
| 1 month | −43.2% | −13.5% |
| 6 months | −74.1% | −43.8% |
| Year to date | −20.9% | −52.0% |
| 1 year | −21.1% | −72.6% |
| Revenue growth (YoY) | −84.6% | +34.9% |
| Gross margin | 100.0% | −203.2% |
| Net margin | −391.6% | −9064.5% |
| P/E (TTM) | — | — |
| Price / sales | 3.3× | 60.3× |
| Net cash | $164.3M | $13.7M |
| Dividend yield | — | — |
| Volatility (60d) | 74.2% | 102.7% |
| Short % of float | 13.1% | 11.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).